~(131)I标记抗人结肠癌单克隆抗体MC_3对裸鼠载人肠癌的放射免疫显像和导向治疗研究

实验动物科学

~(131)I标记抗人结肠癌单克隆抗体MC_3对裸鼠载人肠癌的放射免疫显像和导向治疗研究

许沈华;牟瀚舟;钱丽娟;朱赤红;张奕荫;黄晓曙;张宗显;孙永正;戴珊星;

浙江省肿瘤医院肿瘤研究所,浙江省肿瘤医院肿瘤研究所,浙江省肿瘤医院肿瘤研究所,浙江省肿瘤医院肿瘤研究所,浙江省肿瘤医院肿瘤研究所,浙江省肿瘤医院肿瘤研究所,浙江省肿瘤医院肿瘤研究所,浙江省肿瘤医院肿瘤研究所核医学科,浙江省肿瘤医院肿瘤研究所核医学科杭州 310022,杭州 310022,杭州 310022,杭州 310022,杭州 310022,杭州 310022,杭州 310022,杭州 310022,杭州 310022

收稿日期:1992-12-25 修回日期:1992-12-25 出版日期:1992-12-25 发布日期:1992-12-25

RADIOIMMUNOIMAGING AND TARGETING TREATMENT OF ~(131)I-LABELED MONOCLONAL ANTIBODY MC_3 IN NUDE MICE BEARING HUMAN RECTAL CANCER

Xu Shenhua Mu Hanzhou Qian Lijuan, Cancer Res.Inst of Zhejiang Cancer Hospital,Hangzhou,310022

Received:1992-12-25 Revised:1992-12-25 Online:1992-12-25 Published:1992-12-25

摘要/Abstract

摘要： 用~(131)I标记的抗人结肠癌单克隆抗体(McAbMC_3)对裸鼠载人肠癌进行放射免疫显像诊断和实验性治疗研究。结果显示:体外标记抗体特异性结合率分别为37.5％和32.1％。裸鼠体内在48~120h的ECT照相可见在肿瘤部位均有放射性的特异性浓聚,其摄取量随时间延长逐渐增加,肿瘤显影清晰,显像的合适时间为96～120h。而给予非特异性的~(131)I-NMIgG后肿瘤部位来见放射性浓聚,而呈全身均匀性分布。120h肿瘤组织与肝脏及正常肠组织的比值分别为3.61和9.81,肿瘤定位指数为4.26。实验治疗显示与对照相比~(131)I-MC_3对肿瘤有明显的抑制生长作用,治疗后第14天肿瘤抑制率为90.14％,与~(131)I-NMIgG对照组比较差异极显著(P<0.01)。治疗后第32天裸鼠血清CEA含量与~(131)I-NMIgG组比较差异显著(P<0.05)。病理组织学检查结果显示治疗后8天注射~(131)I-MC_3裸鼠肿瘤呈大片坏死,仅局部肿瘤边缘尚存少数完整的肿瘤细胞,而其它正常组织、器官未见明显辐射损伤。提示McAbMC_3用于肠癌的诊断和导向治疗可能有良好的前景。

关键词: 直肠肿瘤, 放射免疫显像, 导向治疗, 单克隆抗体MC_3, 裸鼠移植瘤

Abstract: Radioimmunoimaging and targeting treatment of ~(131)I-labeled specific monoclonal antibody MC_3 against human colon mucoid adenocarcinoma in tumor-bearing nude mice were studied. The specific binding rate of the monoclonal antibody MC_3 to rectal cancer cells in vitro was 37.5% and 32.1%. In nude mice bearing human rectal cancer xenografts a clear image of tumor was obtained by ECT camera between 48-120 hours after injection of laoeled MC_3 and the concentration of MC_3 in tumor increased with time. The optimal imaging time was 96-120 hrs. after injection. Where as injection of ~(131)I-NMIgG in to the nude mice resulted in an equal distribution in the whole body. 120 hours after injection of ~(131)I-MC_3 the tumor/liver and tumor/normal colon distribution raties were 3.61 and 9.81 respectively and the localization index of tumor was 4.26. Targeting treatment of ~(131)I-MC_3 was found to be able to inhibit 90.14% of tumor growth at 14th day after injection as compared with the control groups. The difference was very significant (P<0.01) as compared with the ~(131)I-NMIgG control group. The difference in the amount of CEA in blood serum of nude mice at 32th day after injection of ~(131)I-MC_3 was significant (P<0.05) as compared with the ~(131)I-NMIgG control group. Histopathological examination showed that in the ~(131)I-MC_3 group at 8th day after injection the tumor showed large areas of necrosis, and only a few round cancer cells werw found near the capsule of the tumor. Inradiation damage was observed in other tissues. The results showed that monoclonal antibody MC_3 may be used in localization and targeting treatment of human colon-rectal cancers.

Key words: Rectal neoplasms, Radioimmunoimaging, Targeting treatment, Monoclonal antibody MC_3, Transplantable

许沈华;牟瀚舟;钱丽娟;朱赤红;张奕荫;黄晓曙;张宗显;孙永正;戴珊星;. ~(131)I标记抗人结肠癌单克隆抗体MC_3对裸鼠载人肠癌的放射免疫显像和导向治疗研究[J]. 实验动物科学.

Xu Shenhua Mu Hanzhou Qian Lijuan, Cancer Res.Inst of Zhejiang Cancer Hospital,Hangzhou,310022. RADIOIMMUNOIMAGING AND TARGETING TREATMENT OF ~(131)I-LABELED MONOCLONAL ANTIBODY MC_3 IN NUDE MICE BEARING HUMAN RECTAL CANCER[J]. laboratory animal science.

[1]	叶燕丽,蔡海英,张彦娜,王连桂. 抗癌药物对人食管癌裸鼠移植瘤株的治疗作用[J]. 实验动物科学, 2002, 19(04): 5-7.
[2]	杨善民,陈福,陈美玉. 移植瘤株冷冻保护的实验研究[J]. 实验动物科学, 1997, 14(01): 21-25.
[3]	林乔，李川江，冯玲玲，何敏，冯楚北，唐利军，章咏裳，李龙承. 抗人膀胱癌单克隆抗体与阿霉素偶联物对裸鼠模型的导向治疗效果的观察[J]. 实验动物科学, 1996, 13(03): 0-0.
[4]	许沈华，牟瀚舟，钱丽娟，孙永正，朱赤红，高永良，肖必文. 必解癌Ⅱ号协同5Fu抗肠癌实验研究[J]. 实验动物科学, 1996, 13(03): 0-0.
[5]	俞莉章;谢蜀生;赵翀;顾方六;. 抗人膀胱癌单抗的导向治疗实验研究[J]. 实验动物科学, 1992, 9(04): 43-43.
[6]	张春丽;王兆绰;俞莉章;潘中允;顾方六;. ~1I-抗膀胱癌单克隆抗体在荷瘤裸鼠的体内分布与放射免疫显像[J]. 实验动物科学, 1992, 9(04): 51-54.